In vitro drug interaction studies of atorvastatin with ciprofloxacin, gatifloxacin, and ofloxacin

被引:0
|
作者
M. Saeed Arayne
Najma Sultana
Syeda Bushra Shakeb Rizvi
Urooj Haroon
机构
[1] University of Karachi,Department of Chemistry
[2] University of Karachi,Department of Pharmaceutical Chemistry, Faculty of Pharmacy
来源
关键词
Atorvastatin; Ciprofloxacin; Gatifloxacin; Ofloxacin; Interactions; Charge-transfer complex;
D O I
暂无
中图分类号
学科分类号
摘要
We describe the in vitro availability of atorvastatin, a potent HMG-CoA reductase inhibitor, in presence of ciprofloxacin, gatifloxacin, and ofloxacin, all with a wide antibacterial spectrum. These studies were performed at 37°C, 48°C, and 60°C in different pH environments, simulating human body compartments. The reactions were studied by UV spectroscopy, and the availability of both the drugs in presence of each other was determined by deriving a simultaneous equation for two component system through modification of Beer’s law. It has been observed that due to interaction, the availability of both atorvastatin and quinolones increased considerably in nearly all pH mediums, which are attributed to the formation of charge-transfer complexes. The results were further confirmed by IR, HNMR, and mass spectrometric studies.
引用
收藏
页码:717 / 731
页数:14
相关论文
共 50 条
  • [41] Interaction of gatifloxacin with efflux transporters: A possible mechanism for drug resistance
    Kwatra, Deep
    Vadlapatla, Ramya Krishna
    Vadlapudi, Aswani Dutt
    Pal, Dhananjay
    Mitra, Ashim K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 395 (1-2) : 114 - 121
  • [42] In vitro drug interaction studies in drug discovery - Higher throughput methods
    Johnson, D
    Janiszewski, J
    Tweedle, D
    PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON LABORATORY AUTOMATION AND ROBOTICS 1996, 1997, : 496 - 496
  • [43] Drug-Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
    Zurth, Christian
    Koskinen, Mikko
    Fricke, Robert
    Prien, Olaf
    Korjamo, Timo
    Graudenz, Kristina
    Denner, Karsten
    Bairlein, Michaela
    Von Buehler, Clemens-Jeremias
    Wilkinson, Gary
    Gieschen, Hille
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (06) : 747 - 759
  • [44] In-vitro drug-drug interaction studies of diltiazem with floroquinolones
    Shafi, Nighat
    Siddiqui, Farhan Ahmed
    Arayne, Muhammad Saeed
    Sultana, Najma
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2017, 40 (20) : 1003 - 1014
  • [45] INTERACTION BETWEEN TACROLIMUS, ATORVASTATIN, AND LEVOFLOXACIN - AN UNREPORTED DRUG-DRUG INTERACTION
    Flecha, Antonette
    Sachdeva, Mala
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (04) : A36 - A36
  • [46] In-vitro activity of gatifloxacin, a novel fluoroquinolone, compared with that of ciprofloxacin against Legionella spp.
    Pendland, SL
    Losnedahl, KJ
    Schriever, CA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (02) : 295 - 297
  • [47] Ciprofloxacin/Gatifloxacin-1,2,3-triazole-isatin Hybrids and Their In Vitro Anticancer Activity
    Jiang, Dan
    Zhang, Guifu
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2019, 56 (10) : 2966 - 2969
  • [48] Timed kill kinetic studies of levofloxacin, ofloxacin, and ciprofloxacin against Moraxella catarrhalis
    Barrett, MS
    Jones, RN
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 30 (02) : 135 - 138
  • [49] Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study
    Hoban, DJ
    Bouchillon, SK
    Johnson, JL
    Zhanel, GG
    Butler, DL
    Miller, LA
    Poupard, JA
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 40 (1-2) : 51 - 57
  • [50] A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies
    Wilton, LV
    Pearce, GL
    Mann, RD
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (04) : 277 - 284